IRIS
CACCIATORE, Ivana
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.035
EU - Europa 4.753
AS - Asia 3.968
SA - Sud America 475
AF - Africa 48
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 3
Totale 15.289
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.901
SG - Singapore 1.583
IT - Italia 1.242
CN - Cina 1.219
IE - Irlanda 677
UA - Ucraina 547
SE - Svezia 501
GB - Regno Unito 474
TR - Turchia 413
BR - Brasile 385
DE - Germania 385
FR - Francia 378
VN - Vietnam 258
IN - India 242
FI - Finlandia 166
RU - Federazione Russa 111
CA - Canada 76
HK - Hong Kong 56
PL - Polonia 55
MX - Messico 41
JP - Giappone 39
AR - Argentina 38
AT - Austria 38
BE - Belgio 34
BD - Bangladesh 33
NL - Olanda 28
ES - Italia 26
KR - Corea 23
CZ - Repubblica Ceca 22
ZA - Sudafrica 20
LT - Lituania 18
IQ - Iraq 17
IR - Iran 16
GR - Grecia 15
EC - Ecuador 13
PK - Pakistan 13
ID - Indonesia 10
CH - Svizzera 9
IL - Israele 8
CL - Cile 7
EU - Europa 7
MA - Marocco 7
PY - Paraguay 7
AE - Emirati Arabi Uniti 6
CO - Colombia 6
JO - Giordania 6
AZ - Azerbaigian 5
KE - Kenya 5
PE - Perù 5
SA - Arabia Saudita 5
TN - Tunisia 5
UY - Uruguay 5
VE - Venezuela 5
CR - Costa Rica 4
DK - Danimarca 4
EG - Egitto 4
PA - Panama 4
RO - Romania 4
DO - Repubblica Dominicana 3
EE - Estonia 3
KW - Kuwait 3
NP - Nepal 3
PT - Portogallo 3
UZ - Uzbekistan 3
AL - Albania 2
AU - Australia 2
BY - Bielorussia 2
CG - Congo 2
CI - Costa d'Avorio 2
GY - Guiana 2
JM - Giamaica 2
LB - Libano 2
NO - Norvegia 2
BG - Bulgaria 1
BN - Brunei Darussalam 1
BO - Bolivia 1
DZ - Algeria 1
GA - Gabon 1
GD - Grenada 1
HN - Honduras 1
HU - Ungheria 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LV - Lettonia 1
ME - Montenegro 1
MT - Malta 1
MY - Malesia 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PH - Filippine 1
RS - Serbia 1
SM - San Marino 1
SR - Suriname 1
TT - Trinidad e Tobago 1
UG - Uganda 1
Totale 15.289
Salva come PNG Salva come JPEG
Città #
Singapore 1.176
Chandler 880
Dublin 669
Jacksonville 647
Ashburn 394
Dallas 333
Beijing 311
Southend 300
Princeton 272
Chieti 253
Izmir 218
Nanjing 192
Los Angeles 177
New York 176
The Dalles 164
Santa Clara 154
Dearborn 151
Ann Arbor 147
Munich 137
Wilmington 122
Pescara 110
Cambridge 98
Altamura 94
Tongling 88
Ho Chi Minh City 83
Boardman 69
Buffalo 65
Nanchang 64
Rome 61
Hong Kong 50
Shenyang 50
Hanoi 45
Dong Ket 43
São Paulo 42
Hefei 41
Helsinki 41
Kunming 39
Redondo Beach 39
Woodbridge 39
Tianjin 38
Warsaw 38
Denver 37
Tokyo 37
Frankfurt am Main 32
Hebei 32
Brussels 31
Milan 31
Seattle 29
Jinan 28
Chicago 27
Falls Church 26
Toronto 25
Houston 24
Nuremberg 24
Turku 24
Vienna 24
Washington 24
London 23
Orem 23
Boston 21
Jiaxing 21
Norwalk 21
Seoul 21
Zhengzhou 21
Chennai 20
Montreal 20
Poplar 20
Brooklyn 19
Brno 18
Grevenbroich 18
Mexico City 18
Atlanta 17
Augusta 17
Kocaeli 17
Manchester 17
Changsha 16
Stockholm 16
Johannesburg 15
San Francisco 15
Ancona 14
Guangzhou 14
Leawood 13
Ningbo 13
Silvi 13
Teramo 13
Amsterdam 12
Brasília 12
Hangzhou 12
Ankara 11
Bologna 11
Moscow 11
Romola 11
Roubaix 11
San Jose 11
Changchun 10
Kraków 10
Lanzhou 10
Naples 10
Rio de Janeiro 10
San Mateo 10
Totale 9.221
Salva come PNG Salva come JPEG
Nome #
Il cofarmaco ibuprofene-glutatione quale nuovo potenziale agente anti-alzheimer 365
Development of glycine-α-methyl-proline-containing tripeptides with neuroprotective properties 182
Chelating and antioxidant properties of l-Dopa containing tetrapeptide for the treatment of neurodegenerative diseases 175
(R)-α-Lipoyl-glycyl-L-prolyl-L-glutamyl dimethyl ester codrug as a multifunctional agent with potential neuroprotective activities 171
Modulation of apoptotic cell death and neuroprotective effects of glutathione—L-Dopa codrug against H2O2-induced cellular toxicity 163
Gold nanoparticles as scaffolds for poor water soluble and difficult to vehiculate antiparkinson codrugs 163
(R)-α-Lipoyl-Gly-L-Pro-L-Glu dimethyl ester as dual acting agent for the treatment of Alzheimer's disease 157
Preparation of boronate derivatives for the treatment of diseases and conditions associated to oxidative stress 157
Carvacrol reduces adipogenic differentiation by modulating autophagy and ChREBP expression 156
A glutathione derivative with chelating and in vitro neuroprotective activities: synthesis, physicochemical properties, and biological evaluation. 153
Synthesis of a novel cyclic prodrug of S -allyl-glutathione able to attenuate LPS-induced ROS production through the inhibition of MAPK pathways in U937 cells 150
Solid lipid nanoparticles loaded with lipoyl-memantine codrug: preparation and characterization 145
Memantine-derived drugs as potential antitumor agents for the treatment of glioblastoma 145
Synthesis of a novel TRH-related sulphonamido peptide 143
Sintesi e valutazione dell’attività antimicrobica di nuovi carvacrolo codrugs 142
NSAID Coniugates for the treatment of Alzheimer's Disease 142
Preparation and characterization of polymeric micelles loaded with a potential anticancer prodrug 137
CNS delivery of L-Dopa by a new Hybrid Glutathione-Methionine peptidomimetic prodrug 136
2,5-Diketopiperazines as neuroprotective agents 136
(R)-alpha-Lipoic Acid–Gly-L-Pro-L-Glu(OMe)-OMe Codrug as Multifunctional Agent for Neurodegenerative Diseases, with Antioxidant and Neuroprotective Properties 136
Effect of MRJF4 on C6 glioma cells proliferation and migration 136
Advances in prodrug design for Parkinson's disease 136
N-Acetyl-L-Methionyl-L-Dopa-Methyl Ester as a dual acting drug that relieves L-Dopa-induced oxidative toxicity 135
A Potent (R)-alpha-bis-lipoyl Derivative Containing 8-Hydroxyquinoline Scaffold: Synthesis and Biological Evaluation of Its Neuroprotective Capabilities in SH-SY5Y Human Neuroblastoma Cells 134
Carvacrol codrugs: A new approach in the antimicrobial plan 134
Cofarmaci L-Dopa-antiossidanti solforati quali nuovi potenziali agenti anti-Parkinson 133
Toxicity assessment of hydroxyapatite nanoparticles in rat liver cell model in vitro 133
Synthesis and preliminary pharmacological evaluation of 2,3,4,8,13a-hexahydro-1H-benzo(5,6)cyclohepta(1,2,3-ef)(3)benzazepine-6,7-diol derivatives as dopamine receptor ligands 132
Carvacrol prodrugs as novel antimicrobial agents 131
GPE and GPE analogues as promising neuroprotective agents 130
Sintesi di trans-2-ammino-5(o 6)-cloro-6(o 5)-idrossi-1-fenil-2,3-diidro-1H-indani quali precursori di derivati a potenziale affinità per i recettori della dopamina 128
Synthesis of Short Cationic Antimicrobial Peptidomimetics Containing Arginine Analogs 128
Synthesis and evaluation of trans-2-amino-5(or 6)-chloro-6(or 5)-hydroxy-1-phenyl-2,3-dihydro-1H-indenes as dopamine receptor ligands 127
Sintesi di trans-2-ammino-1-fenil-5-fluoro-6-idrossi (e 6-fluoro-5-idrossi)-2,3-diidro-1H-indeni quali potenziali ligandi per i recettori dopaminergici 125
New pharmacologic tools against Parkinson's disease: L-Dopa-antioxidant codrugs containing the methionine residue 125
Novel NSAID-derived drugs for the potential treatment of Alzheimer’s disease 125
sintesi ed attività di due analoghi del glutatione a conformazione ristretta 124
Ibuprofen and glutathione conjugate as a potential therapeutic agent for treating Alzheimer's disease 124
Carvacrol and its derivatives as antibacterial agents 122
Synthesis and biological evaluation of novel analogues of Gly-l-Pro-l-Glu (GPE) as neuroprotective agents 122
Synthesis and antioxidant properties of novel memantine derivatives 121
Evaluation of 2,3,4,8,13a hexahydro-1H-Benzo[5,6]cyclohepta-6,7-dihydroxy[1,2,3-ef][3]benzazepine derivatives as dopamine receptor ligands 120
Synthesis and Biological Evaluation of Novel Selenyl and Sulfur-l-Dopa Derivatives as Potential Anti-Parkinson's Disease Agents 120
N-(tert-butilossicarbonil)-beta,beta-ciclopentil-cisteina (acetamidometil)-metil estere per la sintesi di nuovi derivati peptidomimetici 119
Viscoelastic behaviour of hyaluronic acid formulations containing carvacrol prodrugs with antibacterial properties 117
Resveratrol Derivative Exhibits Marked Antiproliferative Actions, Affecting Stemness in Pancreatic Cancer Cells 116
Biochemical properties of new synthetic carnosine analogues containing the residue of 2,3-diaminopropionic acid: the effect of N-acetylation 116
synthesis and Activity of L-Dopa-Thiol antioxidant Co-drugs and New anti-PArkinson Agents with free Radical Scavenging Properties 116
N-(tert)-Butyloxycarbonyl-beta,beta-Cyclopentyl-Cysteine (Acetamidomethyl)-Methyl Ester for Synthesis of Novel Peptidomimetic Derivatives 116
Synthesis and activity of fluorescent glutathione S-conjugates as novel GST inhibitors 115
Synthesis and Study of L-Dopa-Glutathione Codrugs as New Anti-Parkinson Agents with Free Radical Scavenging Properties. 115
Discovery of novel RIP derivatives by alanine scanning for the treatment of S. aureus infections. 115
Solid lipid nanoparticles as a drug delivery system for the treatment of neurodegenerative diseases 112
Nanoencapsulation strategies for the delivery of novel bifunctional antioxidant/σ1 selective ligands 111
L-dopa co-drugs in nanostructured lipid carriers: A comparative study 111
Direct- and spacer-coupled codrug strategies for the treatment of Alzheimer’s disease 110
Synthesis and evaluation of new endomorphoin analogues modified at the Pro2 residue 110
Synthesis and preliminary pharmacological evaluation of trans-2-amino-5(6)-chloro-6(5)-hydroxy-1- phenyl-2,3-dihydro-1H-indenes as dopamine receptor ligands 109
Delivery Methods of Camptothecin and Its Hydrosoluble Analogue Irinotecan for Treatment of Colorectal Cancer 109
synthesis and biological evaluation as anti-Parkinson agent of an analogue of Glutathione-L-Dopa containing methionine in place of the cysteinil residue 108
Memantine-sulphur containing antioxidant conjugates as potential prodrugs to improve the treatment of Alzheimer’s disease 108
RNAIII Inhibiting Peptide (RIP) and derivatives as potential tools for the treatment of S. aureus biofilm infections 108
Emerging Effects of Resveratrol Derivatives in Cells Involved in Oral Wound Healing: A Preliminary Study 106
Codrugs Linking l-Dopa and Sulfur-Containing Antioxidants: New Pharmacological Tools against Parkinson’s Disease 106
Nano-delivery systems based on carvacrol prodrugs and fibrous clays 106
Nuovi S-coniugati del glutatione ad attività inibitoria nei confronti delle GST umane 105
Novel anti-Alzheimer phenol-lipoyl hybrids: Synthesis, physico-chemical characterization, and biological evaluation 105
Synthesis and biological evaluation of a novel pyroglutamil-modified TRH analogue 104
A new chromogenic substrate for pantetheine hydrolase and vanin proteins 104
Synthesis, characterization and evaluation of gemfibrozil-stilbene hybrid as antioxidant agent 104
Preparation and pharmacological characterization of trans-2-amino-5(6)-fluoro-6(5)-hydroxy-1-phenyl-2,3-dihydro-1H-indenes as D2-like dopamine receptor agonists 104
In Vitro Wound-Healing Properties of Water-Soluble Terpenoids Loaded on Halloysite Clay 103
Multiple lipid nanoparticles as antimicrobial drug delivery systems 103
Anticancer effects of novel NSAIDs derivatives on cultured human glioblastoma cells 103
Facile transformation of glutamic acid into proline residue inside a tripeptide backbone 102
Synthesis and activity of endomorphin-2 and morphiceptin analogues with proline surrogates in position 2 100
Role of Dietary Supplements in the Management of Parkinson's Disease 100
Dimeric L-dopa derivatives as potential prodrugs. 99
Structure-Activity relationships of biphalin analogs and their biological evaluation on opioid receptors 99
Transition state isosteres of the gamma-glutamyl peptide bond hydrolysis: synthesis and characterization of the psi (CH2NH) pseudopeptide analogue of glutathione 99
Potent isozyme-selective inhibition of human glutathione S-transferase A1-1 by a novel glutathione S-conjugate 99
Molecular mechanism undelying the cerebral effect of Gly-Pro-Glu tripeptide bound to L-dopa in a Parkinson's animal model 98
MRJF4, a novel histone deacetylase inhibitor, induces p21 mediated autophagy in PC3 prostate cancer cells 98
Synthesis of GPE analogues as potential neuroprotective agents 97
Neuroinflammation and endoplasmic reticulum stress are coregulated by cyclo(His-Pro) to prevent LPS neurotoxicity 96
New bifunctional antioxidant/σ1 agonist ligands: Preliminary chemico-physical and biological evaluation 96
Carvacrol prodrugs with antimicrobial activity loaded on clay nanocomposites 96
Proline-Glutamate Chimeras in Isopeptides. Synthesis and Biological Evaluation of Conformationally Restricted Glutathione Analogues 95
The efficacy of the quorum sensing inhibitor FS8 and tigecycline in preventing prosthesis biofilm in an animal model of staphylococcal infection. 95
New Flurbiprofen Derivatives: Synthesis, Membrane Affinity and Evaluation of in Vitro Effect on β-Amyloid Levels 95
Cytotoxicity and genotoxicity of iron oxide nanoparticles: An in vitro biosafety study 95
Design, synthesis and evaluation of new endomorphin analogues incorporating constrained aminoacids in place of Pro2 residue 94
Conformationally Constrained Histidines in the Design of Peptidomimetics: Strategies for the χ-Space Control 94
Recent advances in the treatment of neurodegenerative diseases based on GSH delivery systems. 94
Discovery of Small Molecule Vanin Inhibitors: New Tools To Study Metabolism and Disease 94
Hepatic effects of yttrium oxide nanoflowers: in vitro risk evaluation 94
Natural oxyprenylated coumarins are modulators of melanogenesis 94
Synthesis and activity of novel glutathione analogues containing an urethane backbone linkage 93
Prodrug approach for increasing cellular glutathione levels 93
Quorum sensing inhibitor FS3-coated vascular graft enhances daptomycin efficacy in a rat model of staphylococcal infection 93
Totale 12.095
Salva come PNG Salva come JPEG
Categoria #
all - tutte 64.257
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 64.257
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021543 0 0 0 0 0 146 19 25 90 108 72 83
2021/2022749 32 22 10 74 88 33 36 50 103 33 70 198
2022/20232.378 177 358 155 258 212 451 114 216 281 47 54 55
2023/20241.295 97 66 72 47 63 409 273 70 20 22 25 131
2024/20253.166 161 584 519 119 42 188 111 177 255 156 354 500
2025/20263.142 544 289 572 803 639 295 0 0 0 0 0 0
Totale 15.778